Quantification of endothelial microparticles on modified cytometric bead assay and prognosis in chest pain patients

Circulation Journal

Volumn 78, Issue 1, 2014, Pages 206-214

  Fan, Yuqi ^a   Wang, Liansheng ^a   Li, Yuanmin ^a   Yin, Zhaofang ^a   Xu, Zuojun ^a   Wang, Changqian ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Acute coronary syndrome; Chest pain; Endothelial microparticles; Prognosis; Risk factor

Indexed keywords

CD14 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIN 1; FIBRINOGEN RECEPTOR; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CYTOMETRIC BEAD ASSAY; DIABETES MELLITUS; ENDOTHELIAL MICROPARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; IMMUNOASSAY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT REPEATABILITY; PREDICTION; PROGNOSIS; PROTEIN EXPRESSION; RISK FACTOR; SCANNING ELECTRON MICROSCOPY; SENSITIVITY AND SPECIFICITY; STABLE ANGINA PECTORIS; THORAX PAIN;

AGED; CELL-DERIVED MICROPARTICLES; CHEST PAIN; CORONARY ARTERY DISEASE; DIABETES MELLITUS; ENDOTHELIAL CELLS; ENDOTHELIN-1; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; PROGNOSIS;

EID: 84891104946     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-13-0488     Document Type: Article

References (35)

1. Desideri G, Ferri C. Endothelial activation. Sliding door to atherosclerosis. Curr Pharm Des 2005; 11: 2163-2175.
2. Ribeiro F, Alves AJ, Teixeira M, Ribeiro V, Duarte JA, Oliveira J. Endothelial function and atherosclerosis: Circulatory markers with clinical usefulness. Rev Port Cardiol 2009; 28: 1121-1151.
3. Versari D, Daghini E, Virdis A, Ghiadoni L, Taddei S. Endothelial dysfunction as a target for prevention of cardiovascular disease. Diabetes Care 2009; 32 (Suppl 2): S314-S321.
4. Dohi T, Miyauchi K, Iesaki T, Tsuruta R, Tsuboi S, Ogita M, et al. Candesartan with pioglitazone protects against endothelial dysfunction and inflammatory responses in porcine coronary arteries implanted with sirolimus-eluting stents. Circ J 2011; 75: 1098-1106.
5. Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. NEJM 1986; 315: 1046-1051.
6. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340 (8828): 1111-1115.
7. Kapiotis S, Jilma B, Szalay T, Dirnberger E, Wagner O, Eichler HG, et al. Evidence against an effect of endothelin-1 on blood coagulation, fibrinolysis, and endothelial cell integrity in healthy men. Arterioscler Thromb Vasc Biol 1997; 17: 2861-2867.
8. Khare A, Shetty S, Ghosh K, Mohanty D, Chatterjee S. Evaluation of markers of endothelial damage in cases of young myocardial infarction. Atherosclerosis 2005; 180: 375-380.
9. Kietadisorn R, Juni RP, Moens AL. Tackling endothelial dysfunction by modulating NOS uncoupling: New insights into its pathogenesis and therapeutic possibilities. Am J Physiol Endocrinol Metab 2012; 302: E481-E495.
10. Horstman LL, Jy W, Jimenez JJ, Ahn YS. Endothelial microparticles as markers of endothelial dysfunction. Front Biosci 2004; 9: 1118-1135.
11. Boulanger CM, Leroyer AS, Amabile N, Tedgui A. Circulating endothelial microparticles: A new marker of vascular injury. Ann Cardiol Angeiol (Paris) 2008; 57: 149-154.
12. Chironi GN, Boulanger CM, Simon A, Dignat-George F, Freyssinet JM, Tedgui A. Endothelial microparticles in diseases. Cell Tissue Res 2009; 335: 143-151.
13. Faure V, Dou L, Sabatier F, Cerini C, Sampol J, Berland Y, et al. Elevation of circulating endothelial microparticles in patients with chronic renal failure. J Thromb Haemost 2006; 4: 566-573.
14. Freyssinet JM, Dignat-George F. More on: Measuring circulating cell-derived microparticles. J Thromb Haemost 2005; 3: 613-614.
15. Meziani F, Tesse A, Andriantsitohaina R. Microparticles are vectors of paradoxical information in vascular cells including the endothelium: Role in health and diseases. Pharmacol Rep 2008; 60: 75-84.
16. Sinning JM, Losch J, Walenta K, Böhm M, Nickenig G, Werner N. Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes. Eur Heart J 2011; 32: 2034-2041.
17. Lackner P, Dietmann A, Beer R, Fischer M, Broessner G, Helbok R, et al. Cellular microparticles as a marker for cerebral vasospasm in spontaneous subarachnoid hemorrhage. Stroke 2010; 41: 2353-2357.
18. Guiducci S, Ricci L, Romano E, Ceccarelli C, Distler JH, Miniati I, et al. Microparticles and Kawasaki disease: A marker of vascular damage? Clin Exp Rheumatol 2011; 29 (1 Suppl 64): S121-S125.
19. Biasucci LM, Porto I, Di Vito L, De Maria GL, Leone AM, Tinelli G, et al. Differences in microparticle release in patients with acute coronary syndrome and stable angina. Circ J 2012; 76: 2174-2182.
20. Reriani MK, Flammer AJ, Jama A, Lerman LO, Lerman A. Novel functional risk factors for the prediction of cardiovascular events in vulnerable patients following acute coronary syndrome. Circ J 2012; 76: 778-783.
21. Gelderman MP, Simak J. Flow cytometric analysis of cell membrane microparticles. Methods Mol Biol 2008; 484: 79-93.
22. Shet AS. Characterizing blood microparticles: Technical aspects and challenges. Vasc Health Risk Manag 2008; 4: 769-774.
23. Aupeix K, Hugel B, Martin T, Bischoff P, Lill H, Pasquali JL, et al. The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection. J Clin Invest 1997; 99: 1546-1554.
24. Hugel B, Zobairi F, Freyssinet J-M. Measuring circulating cell-derived microparticles: Solid-phase capture assay for the determination of cellular microparticles and associated deleterious potentials. J Thromb Haemost 2004; 2: 1846-1847.
25. Carson RT, Vignali DA. Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay. J Immunol Methods 1999; 227: 41-52.
26. Morgan E, Varro R, Sepulveda H, Ember JA, Apgar J, Wilson J, et al. Cytometric bead array: A multiplexed assay platform with applications in various areas of biology. Clin Immunol 2004; 110: 252-266.
27. Zhou Z, Connell MC, MacEwan DJ. TNFR1-induced NF-kappaB, but not ERK, p38MAPK or JNK activation, mediates TNF-induced ICAM-1 and VCAM-1 expression on endothelial cells. Cell Signal 2007; 19: 1238-1248.
28. Cannon CP, Battler A, Brindis RG, Cox JL, Ellis SG, Every NR, et al. American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). J Am Coll Cardiol 2001; 38: 2114-2130.
29. Biro E, Nieuwland R, Sturk A. Measuring circulating cell-derived microparticles. J Thromb Haemost 2004; 2: 1843-1844.
30. Berk BC, Abe JI, Min W, Surapisitchat J, Yan C. Endothelial atheroprotective and anti-inflammatory mechanisms. Ann NY Acad Sci 2001; 947: 93-109.
31. Nomura S. Measuring circulating cell-derived microparticles: Measurement of platelet microparticles by ELISA. J Thromb Haemost 2004; 2: 1847-1848.
32. Vignali DA. Multiplexed particle-based flow cytometric assays. J Immunol Methods 2000; 243: 243-255
33. Elshal MF, McCoy JP. Multiplex bead array assays: Performance evaluation and comparison of sensitivity to ELISA. Methods 2006; 38: 317-323.
34. Mudau M, Genis A, Lochner A, Strijdom H. Endothelial dysfunction: The early predictor of atherosclerosis. Cardiovasc J Afr 2012; 23: 222-231.
35. Nozaki T, Sugiyama S, Koga H, Sugamura K, Ohba K, Matsuzawa Y, et al. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease. J Am Coll Cardiol 2009; 54: 601-608.